Publication | Open Access

Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

Hematological MalignancyLymphoid NeoplasiaOncologyMedicineMixed-phenotype Acute LeukemiaHematologyPharmacotherapyBendamustine HclPhase-i/ii StudyPharmacologyB-chronic Lymphocytic Leukaemia